CLINICAL_TRIALS
other
· 2025-03-14
Clinical Trial Update: EAP of Apitegromab for Patients With Spinal Muscular Atrophy
Summary
This document provides an update on the expanded access program for Apitegromab in patients with spinal muscular atrophy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Scholar Rock, Inc. | Conditions: SMA | Status: AVAILABLE